Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice
Open Access
- 27 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 138 (22) , 2513-2526
Abstract
Background: Atherosclerotic cardiovascular disease is a chronic inflammatory process initiated when cholesterol-carrying low-density lipoprotein (LDL) is retained in the arterial wall. CD4 + T cells, some of which recognize peptide components of LDL as antigen, are recruited to the forming lesion, resulting in T-cell activation. Although these T cells are thought to be proatherogenic, LDL immunization reduces disease in experimental animals. These seemingly contradictory findings have hampered the development of immune-based cardiovascular therapy. The present study was designed to clarify how activation of LDL-reactive T cells impacts on metabolism and vascular pathobiology. Methods: We have developed a T-cell receptor–transgenic mouse model to characterize the effects of immune reactions against LDL. Through adoptive cell transfers and cross-breeding to hypercholesterolemic mice expressing the antigenic human LDL protein apolipoprotein B-100, we evaluate the effects on atherosclerosis. Results: A subpopulation of LDL-reactive T cells survived clonal selection in the thymus, developed into T follicular helper cells in lymphoid tissues on antigen recognition, and promoted B-cell activation. This led to production of anti-LDL immunoglobulin G antibodies that enhanced LDL clearance through immune complex formation. Furthermore, the cellular immune response to LDL was associated with increased cholesterol excretion in feces and with reduced vascular inflammation. Conclusions: These data show that anti-LDL immunoreactivity evokes 3 atheroprotective mechanisms: antibody-dependent LDL clearance, increased cholesterol excretion, and reduced vascular inflammation.Keywords
This publication has 50 references indexed in Scilit:
- Chemokines: established and novel targets in atherosclerosisEMBO Molecular Medicine, 2011
- T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouseJournal of Experimental Medicine, 2011
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- B cell depletion reduces the development of atherosclerosis in miceJournal of Experimental Medicine, 2010
- Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisJournal of Experimental Medicine, 2010
- FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceThe Journal of Immunology, 2010
- Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (−/−) miceBiochemical and Biophysical Research Communications, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunityCell, 1993
- Lipoprotein-antibody immune complexes their catabolism and role in foam cell formationAtherosclerosis, 1985